DIALOG+ trial

  • Research type

    Research Study

  • Full title

    Implementing the DIALOG Outcome Measure and a Solution-Focused Intervention (DIALOG+) in a Psychiatric Rehabilitation Inpatient Setting: A Mixed Methods Feasibility Study.

  • IRAS ID

    338942

  • Contact name

    Sinead McLernon

  • Contact email

    smclernon1@sheffield.ac.uk

  • Sponsor organisation

    The University of Sheffield

  • Clinicaltrials.gov Identifier

    NCT06476483

  • Duration of Study in the UK

    0 years, 5 months, 1 days

  • Research summary

    This study aims to understand if implementing DIALOG+ in an inpatient psychiatric rehabilitation setting is feasible (can the intervention be implemented) and acceptable (how the intervention is perceived by staff and patient participants). If the intervention is proven to be feasible and acceptable a larger-scale study may take place. This study has been developed in response to the trust-wide implementation of DIALOG outcome measures. DIALOG+ offers additional solution-focused and person-centred follow-up questions to the DIALOG questions and links to MDT discussions. It is hoped that the conversations had during DIALOG+ meetings will support positive outcomes, and the learning gathered from this study will drive change and improvement for other people requiring psychiatric rehabilitation inpatient admissions in the future. DIALOG+ has been successfully implemented in community settings in the NHS but has not been implemented in psychiatric rehabilitation inpatient settings. This study will aim to recruit patient and staff participants from NHS psychiatric rehabilitation inpatient wards. Patient participants who will be eligible to take part are those who can consent, are between the ages of 18-65, and can complete DIALOG and DIALOG+. To understand the feasibility of the intervention, descriptive statistics will be collected and to understand acceptability focus groups will take place and surveys will be collected. Quantitative data collection will take place over 5 months and participants will be split into 2 groups. Group one will be a comparison group where participants will act as an extended baseline group and biweekly DIALOG outcomes will be collected. Group two will be a treatment group and participants will receive the DIALOG+ intervention intervention, DIALOG outcomes will be collected biweekly as part of the intervention. Finally, there will be a period to gather qualitative feedback from patient participants using surveys, and from staff participants using focus groups or semi-structured interviews.

  • REC name

    South Central - Berkshire Research Ethics Committee

  • REC reference

    24/SC/0209

  • Date of REC Opinion

    9 Jul 2024

  • REC opinion

    Further Information Favourable Opinion